Detalles de la búsqueda
1.
Structure-activity studies for a novel series of N-(arylethyl)-N-(1,2,3,4-tetrahydronaphthalen-1-ylmethyl)-N-methylamine s possessing dual 5-HT uptake inhibiting and alpha2-antagonistic activities.
J Med Chem
; 40(7): 1049-62, 1997 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-9089327
2.
Structure-activity studies for a novel series of tricyclic substituted hexahydrobenz[e]isoindole alpha(1A) adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia (BPH).
J Med Chem
; 43(8): 1586-603, 2000 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-10780916
3.
Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.
J Med Chem
; 44(12): 1971-85, 2001 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-11384242
4.
Synthesis and pharmacological characterization of 3-[2-((3aR,9bR)-cis-6-methoxy-2,3,3a,4,5,9b-hexahydro-1H-benz[e] isoindol-2-yl)ethyl]pyrido-[3',4':4,5]thieno[3,2-d]pyrimidine-2,4 (1H,3H)-dione (A-131701): a uroselective alpha 1A adrenoceptor antagonist for the symptomatic treatment of benign prostatic hyperplasia.
J Med Chem
; 40(20): 3141-3, 1997 Sep 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-9379432
5.
Two novel and potent 3-[(o-methoxyphenyl)piperazinylethyl]-5-phenylthien.
Bioorg Med Chem Lett
; 11(9): 1119-21, 2001 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-11354357
Resultados
1 -
5
de 5
1
Próxima >
>>